Skip to main content
Terug
SBRA logo

Sabra Health Care REIT, Inc.

Datakwaliteit: 100%
SBRA
NASDAQ Real Estate REIT - Healthcare Facilities
€ 19,69
▲ € 0,10 (0,51%)
Marktkapitalisatie: 4,96B
Dagbereik
€ 19,67 € 20,03
52-Weeksbereik
€ 15,75 € 21,07
Volume
2.378.787
50D / 200D Gem.
€ 19,74 / € 18,86
Vorige Slotkoers
€ 19,59

Koershistorie

Financiële Trends

Sectorvergelijking

vs Real Estate sector mediaan (361 peers)

Metriek Aandeel Sector Mediaan
P/E 31,9 11,1
P/B 1,8 0,8
ROE % 5,6 6,1
Net Margin % 20,1 19,9
Rev Growth 5Y % 8,0 7,0
D/E 0,9 0,9

Koersdoel Analisten

Hold
€ 21,33 +8.3%
Low: € 21,00 High: € 22,00
Forward K/W
28,4
Forward WPA
€ 0,69
WPA Groei (sch.)
+0,0%
Omzet Sch.
840 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2030 € 0,00
€ 0,00 – € 0,00
1,4 B 0
FY2029 € 0,84
€ 0,79 – € 0,90
1,1 B 1
FY2028 € 0,81
€ 0,79 – € 0,84
890 M 2

Belangrijkste Punten

Revenue grew 7,99% annually over 5 years — modest growth
Earnings grew 22,81% over the past year
Net margin of 20,09% shows strong profitability
Generating 348,61M in free cash flow
P/E of 31,91 — premium valuation
Cash machine — converts 224,03% of earnings into free cash flow

Groei

Revenue Growth (5Y)
7,99%
Revenue (1Y)10,15%
Earnings (1Y)22,81%
FCF Growth (3Y)7,70%

Kwaliteit

Return on Equity
5,59%
ROIC3,68%
Net Margin20,09%
Op. Margin34,06%

Veiligheid

Debt / Equity
0,90
Current Ratio0,15
Interest Coverage2,35

Waardering

P/E Ratio
31,91
P/B Ratio1,76
EV/EBITDA28,21
Dividend Yield0,06%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 10,15% Revenue Growth (3Y) 9,38%
Earnings Growth (1Y) 22,81% Earnings Growth (3Y) 236,33%
Revenue Growth (5Y) 7,99% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 774,63M Net Income (TTM) 155,61M
ROE 5,59% ROA 2,83%
Gross Margin 65,00% Operating Margin 34,06%
Net Margin 20,09% Free Cash Flow (TTM) 348,61M
ROIC 3,68% FCF Growth (3Y) 7,70%
Safety
Debt / Equity 0,90 Current Ratio 0,15
Interest Coverage 2,35 Dividend Yield 0,06%
Valuation
P/E Ratio 31,91 P/B Ratio 1,76
P/S Ratio 6,41 PEG Ratio 1,59
EV/EBITDA 28,21 Dividend Yield 0,06%
Market Cap 4,96B Enterprise Value 7,44B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 774,63M 703,24M 647,51M 624,81M 569,55M
Net Income 155,61M 126,71M 13,76M -77,61M -113,26M
EPS (Diluted) 0,64 0,54 0,06 -0,34 -0,52
Gross Profit 503,53M 476,15M 452,27M 462,20M 428,34M
Operating Income 263,87M 257,03M 221,71M 234,84M 210,75M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5,49B 5,30B 5,39B 5,75B 5,97B
Total Liabilities 2,67B 2,56B 2,58B 2,69B 2,59B
Shareholders' Equity 2,82B 2,74B 2,80B 3,06B 3,38B
Total Debt 2,55B 2,44B 2,45B 2,55B 2,44B
Cash & Equivalents 71,54M 60,47M 41,29M 49,31M 112,00M
Current Assets 182,83M 198,09M 180,53M 201,84M 253,99M
Current Liabilities 1,26B 224,45M 231,41M 339,24M 142,99M

Strategiescores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#446 of 1024
48

Recente Activiteit

Ingestapt Cash Flow Compounder
Mar 24, 2026